• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BLUE BELT TECHNOLOGIES NAVIO SURGICAL SYSTEM BE/FR/DE; ORTHOPEDIC STEREOTAXIC INSTRUMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BLUE BELT TECHNOLOGIES NAVIO SURGICAL SYSTEM BE/FR/DE; ORTHOPEDIC STEREOTAXIC INSTRUMENT Back to Search Results
Catalog Number NPFS02020
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Tissue Injury (4559); Insufficient Information (4580)
Event Date 04/04/2021
Event Type  Injury  
Event Description
It was reported that on literature review "improved sizing with image-based robotic-assisted system compared to image-free and conventional techniques in medial unicompartmental knee arthroplasty", ninety three (93) patients underwent a primary uka procedure assisted with a navio robotic surgical system where cemented journey ii uni implants were used.From these patients, a total of nineteen (19) patients had a femoral component undersizing diagnosis defined as a distance reduction between the cortex and the femoral implant edge greater than 3mm when compared with preoperative x-rays.These nineteen (19) patients included: two (2) patients with undersizing related to the anterior femur measured as the distance between the cortex and the anterior edge of the femoral component when assessed on an ap radiograph, seven (7) patients with undersizing related to the posterior femur measured as the distance between the cortex and the posterior edge of the femoral component when assessed on a ap radiograph and ten (10) patients with undersizing related to the posterior femoral offset restoration measured as the distance between the axis of the posterior cortex of the femoral diaphysis and the posterior part of the femoral condyle.No additional details were provided regarding the clinical symptoms experienced by each patient, if any.The outcome of all patients is unknown.No further information is available.
 
Manufacturer Narrative
Internal complaint reference (b)(4).Article cite: batailler, c., bordes, m., lording, t., nigues, a., servien, e., calliess, t., & lustig, s.(2021).Improved sizing with image-based robotic-assisted system compared to image-free and conventional techniques in medial unicompartmental knee arthroplasty.The bone & joint journal, 103-b(4), 610¿618.Https://doi.Org/10.1302/0301-620x.103b4.Bjj-2020-1453.R1.
 
Manufacturer Narrative
Section h10: the navio surgical system be/fr/de, part number npfs02020, used for treatment was not returned for evaluation.A relationship between the reported event and the device could not be established.The clinical/medical investigation concluded that the author has provided radiological assessment of the imaging within the text; therefore, further analysis is not warranted.As of the date of this medical investigation, patient specific documentation has not been received; therefore, no clinical factors were concluded to have contributed to the reported events.The patient impact beyond the reported undersized femoral components could not be determined based on the limited information provided in the literature.No further medical assessment can be rendered at this time.A complaint history review for similar reported/confirmed complaints has identified prior events.While all products meet required manufacturing specifications prior to release a serial number, lot number, part revision or software version is required to link the device to a dhr or nc investigation.As with any surgical procedure, there is risk involved.Potential complications accompanying surgery may occur, including: allergic reaction (anaphylactic and minor), infection, mild to serious physical injury, localized static shock, delay in the operation, surgical site nerve injury, vascular injuries of the lower extremity, soft tissue damage, major bone gouging at the surgical site, bone fracture, immature implant failure, unstable knee joint, limited or restricted knee range of motion, major blunt impact injury, unintended laceration/puncture wound, and osteonecrosis.The failure mode and associated risk have been anticipated within the risk file.The risk level is still adequate.Although the reported problem was not confirmed through a visual or functional evaluation, factors contributing to the reported symptom may have been associated with incomplete points collection.Based on the investigation, the need for a corrective action is not recommended or required at this time.Should any additional information be received the complaint will be reopened.The failure mode will continue to be closely monitored through complaint investigation and trended through post market surveillance activities.Internal complaint reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVIO SURGICAL SYSTEM BE/FR/DE
Type of Device
ORTHOPEDIC STEREOTAXIC INSTRUMENT
Manufacturer (Section D)
BLUE BELT TECHNOLOGIES
2905 northwest blvd ste 40
plymouth MN 55441
Manufacturer (Section G)
BLUE BELT TECHNOLOGIES
2905 northwest blvd ste 40
plymouth MN 55441
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key15251393
MDR Text Key298152735
Report Number3010266064-2022-00570
Device Sequence Number1
Product Code OLO
Combination Product (y/n)N
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,User Facility
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberNPFS02020
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/01/2022
Initial Date FDA Received08/18/2022
Supplement Dates Manufacturer Received11/13/2022
Supplement Dates FDA Received11/15/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-